141 related articles for article (PubMed ID: 2526844)
1. The binding of steroids to myometrium and leiomyomata (fibroids) in women treated with the gonadotrophin-releasing hormone agonist Zoladex (ICI 118630).
Lumsden MA; West CP; Hawkins RA; Bramley TA; Rumgay L; Baird DT
J Endocrinol; 1989 May; 121(2):389-96. PubMed ID: 2526844
[TBL] [Abstract][Full Text] [Related]
2. Steroid receptor binding and messenger RNA expression in fibroids from untreated and gonadotrophin-releasing hormone agonist pretreated women.
Vollenhoven BJ; Pearce P; Herington AC; Healy DL
Clin Endocrinol (Oxf); 1994 Apr; 40(4):537-44. PubMed ID: 8187322
[TBL] [Abstract][Full Text] [Related]
3. Effect of treatment with LHRH analogue Zoladex on binding of oestradiol, progesterone and epidermal growth factor to uterine fibromyomata.
Baird DT; Bramley TA; Hawkins TA; Lumsden MA; West CP
Horm Res; 1989; 32 Suppl 1():154-6. PubMed ID: 2533146
[TBL] [Abstract][Full Text] [Related]
4. The binding of epidermal growth factor to the human uterus and leiomyomata in women rendered hypo-oestrogenic by continuous administration of an LHRH agonist.
Lumsden MA; West CP; Bramley T; Rumgay L; Baird DT
Br J Obstet Gynaecol; 1988 Dec; 95(12):1299-304. PubMed ID: 2975953
[TBL] [Abstract][Full Text] [Related]
5. [Preoperative reduction of uterine leiomyoma by the GnRH-analog goserelin (zoladex)].
Hackenberg R; Gesenhues T; Deichert U; Duda V; Sturm G; Schulz KD
Geburtshilfe Frauenheilkd; 1990 Feb; 50(2):136-9. PubMed ID: 2138580
[TBL] [Abstract][Full Text] [Related]
6. Total and unbound cytosolic estrogen and progesterone receptors in myometrium and fibroid after gonadotropin-releasing hormone agonist treatment.
Fernández-Montolí ME; Díez-Gibert O; Samaniego JM; Balagueró L; Navarro MA
Fertil Steril; 1995 Mar; 63(3):522-7. PubMed ID: 7851581
[TBL] [Abstract][Full Text] [Related]
7. Shrinkage of uterine fibroids during therapy with goserelin (Zoladex): a luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depot.
West CP; Lumsden MA; Lawson S; Williamson J; Baird DT
Fertil Steril; 1987 Jul; 48(1):45-51. PubMed ID: 2954863
[TBL] [Abstract][Full Text] [Related]
8. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
Murphy AA; Kettel LM; Morales AJ; Roberts VJ; Yen SS
J Clin Endocrinol Metab; 1993 Feb; 76(2):513-7. PubMed ID: 8432797
[TBL] [Abstract][Full Text] [Related]
9. Gene expression and tissue concentrations of IGF-I in human myometrium and fibroids under different hormonal conditions.
Englund K; Lindblom B; Carlström K; Gustavsson I; Sjöblom P; Blanck A
Mol Hum Reprod; 2000 Oct; 6(10):915-20. PubMed ID: 11006320
[TBL] [Abstract][Full Text] [Related]
10. Sex steroid receptors in human myometrium and fibroids: changes during the menstrual cycle and gonadotropin-releasing hormone treatment.
Englund K; Blanck A; Gustavsson I; Lundkvist U; Sjöblom P; Norgren A; Lindblom B
J Clin Endocrinol Metab; 1998 Nov; 83(11):4092-6. PubMed ID: 9814497
[TBL] [Abstract][Full Text] [Related]
11. Fibroid and myometrial steroid receptors in women treated with gonadotropin-releasing hormone agonist leuprolide acetate.
Rein MS; Friedman AJ; Stuart JM; MacLaughlin DT
Fertil Steril; 1990 Jun; 53(6):1018-23. PubMed ID: 2112489
[TBL] [Abstract][Full Text] [Related]
12. [New possibilities for differentiated therapy of leiomyoma of the uterus using the GnRH agonist zoladex].
Gesenhues T; Hackenberg R; Diechert U; Duda V; Sturm G; Schulz KD
Geburtshilfe Frauenheilkd; 1989 Feb; 49 Suppl 1():96-8. PubMed ID: 2522904
[TBL] [Abstract][Full Text] [Related]
13. Tissue differences but limited sex steroid responsiveness of c-fos and c-jun in human fibroids and myometrium.
Gustavsson I; Englund K; Faxén M; Sjöblom P; Lindblom B; Blanck A
Mol Hum Reprod; 2000 Jan; 6(1):55-9. PubMed ID: 10611261
[TBL] [Abstract][Full Text] [Related]
14. The short-term use of luteinising hormone-releasing hormone analogues in uterine fibroids.
Van der Spuy ZM; Fieggan AG; Wood MJ; Pienaar CA
Horm Res; 1989; 32 Suppl 1():137-40. PubMed ID: 2533144
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical localization of epidermal growth factor receptor in leiomyomas from women treated with goserelin depot.
Leone M; Cucuccio S; Venturini PL; Valenzano-Menada M; Messeni Leone M; De Cecco L
Horm Metab Res; 1991 Sep; 23(9):442-5. PubMed ID: 1835956
[TBL] [Abstract][Full Text] [Related]
16. Oestrogen and progesterone receptor concentrations in leiomyoma and normal myometrium.
Sadan O; van Iddekinge B; van Gelderen CJ; Savage N; Becker PJ; van der Walt LA; Robinson M
Ann Clin Biochem; 1987 May; 24 ( Pt 3)():263-7. PubMed ID: 3606010
[TBL] [Abstract][Full Text] [Related]
17. Thioredoxin expression in human myometrium and fibroids.
Sahlin L; Wang H; Lindblom B; Eriksson H; Holmgren A; Blanck A
Mol Hum Reprod; 2000 Jan; 6(1):60-7. PubMed ID: 10611262
[TBL] [Abstract][Full Text] [Related]
18. Potential role for medroxyprogesterone acetate as an adjunct to goserelin (Zoladex) in the medical management of uterine fibroids.
West CP; Lumsden MA; Hillier H; Sweeting V; Baird DT
Hum Reprod; 1992 Mar; 7(3):328-32. PubMed ID: 1534089
[TBL] [Abstract][Full Text] [Related]
19. Goserelin (Zoladex) in the treatment of fibroids.
West CP; Lumsden MA; Baird DT
Br J Obstet Gynaecol; 1992 Feb; 99 Suppl 7():27-30. PubMed ID: 1532507
[No Abstract] [Full Text] [Related]
20. Progesterone, estradiol and their receptors in leiomyomata and the adjacent normal myometria of black Kenyan women.
Wango EO; Tabifor HN; Muchiri LW; Sekadde-Kigondu C; Makawiti DW
Afr J Health Sci; 2002; 9(3-4):123-8. PubMed ID: 17298155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]